SCHEMBL10072445

SCHEMBL10072445

CC(C)COC(C)ONC(=O)/C=C/c1ccc(C=O)nc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 10/20 0.40
HDAC8 Q9BY41 9/20 0.40
HDAC3 O15379 8/20 0.40
HDAC2 Q92769 6/20 0.40
HDAC4 P56524 6/20 0.40
HDAC6 Q9UBN7 6/20 0.40
HDAC7 Q8WUI4 5/20 0.40
HDAC10 Q969S8 5/20 0.40
HDAC11 Q96DB2 5/20 0.40
HDAC9 Q9UKV0 5/20 0.40
HDAC5 Q9UQL6 5/20 0.40
KDM4E B2RXH2 1/20 0.37
TAS1R3 Q7RTX0 3/20 0.36
TAS1R1 Q7RTX1 3/20 0.36
NAMPT P43490 2/20 0.35
NOS3 P29474 2/20 0.34
NOS1 P29475 2/20 0.34
NOS2 P35228 2/20 0.34
TRPV1 Q8NER1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3784072 0.92 HDAC3 (0.38) HDAC1HDAC8HDAC3HDAC2HDAC4
SCHEMBL3784075 0.92 HDAC3 (0.38) HDAC1HDAC8HDAC3HDAC2HDAC4
SCHEMBL1411073 0.86 TAS1R3 (0.40) HDAC1HDAC8HDAC3HDAC2HDAC6
SCHEMBL1411075 0.86 TAS1R3 (0.40) HDAC1HDAC8HDAC3HDAC2HDAC6
SCHEMBL1411360 0.81 MAOB (0.50) HDAC1HDAC8HDAC3HDAC2HDAC4
SCHEMBL1411363 0.81 MAOB (0.50) HDAC1HDAC8HDAC3HDAC2HDAC4
SCHEMBL1411065 0.79 SLC6A19 (0.39) HDAC1HDAC8HDAC3HDAC2HDAC4
SCHEMBL1411066 0.79 SLC6A19 (0.39) HDAC1HDAC8HDAC3HDAC2HDAC4
SCHEMBL1411171 0.76 TAS1R3 (0.46) HDAC1HDAC8HDAC3HDAC2HDAC4
SCHEMBL1411166 0.76 TAS1R3 (0.46) HDAC1HDAC8HDAC3HDAC2HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012025701-A1 ALPHA, ALPHA - DI SUBSTITUTED GLYCINE ESTER DERIVATIVES AND THEIR USE AS HDAC INHIBITORS CHROMA THERAPEUTICS LTD. (GB) 2012-03-01 WO disclosed